Targeting Stat3 With G-Quartet Oligonucleotides in Metastatic Prostate Cancer
Abstract
This annual report is composed of (1) introduction of the goal of this project and specific aims, (2) body of research accomplishments in PI's group from 4/1/04 to 3/31/05, (3) reportable outcomes, and (4) conclusion of researches from 4/1/04 to 3/31/05. The report demonstrated that during the period from 4/1/04 to 3/31/05, PI group made a significant progress in developing a novel and potent anti-cancer agent, which holds promise for the systemic treatment of prostate cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2005
- Accession Number
- ADA438389
Entities
People
- Naijie Jing
Organizations
- Brigham and Women's Hospital